[Effect of the association propofol-alfentanil on bronchial resistances in asthmatic patients].
The bronchial resistances in 17 patients scheduled for ENT surgery were studied during general anaesthesia carried out with propofol and alfentanil. There were nine controls, all free from any allergic pathology. The other eight had bronchial hyperreactivity, with clinical asthma (one or two crises a month) treated with bronchodilators. Two had a complete Fernand-Widal syndrome, and the remaining six documented allergic asthma. All the patients were premedicated with hydroxyzine 2 mg.kg-1 orally on the eve of surgery, and two hours beforehand. Those patients who were on bronchodilators were given their drugs as usual with the premedication. Because bronchial resistances were measured with the patient breathing spontaneously (forced oscillation technique), induction was carried out in two steps, first with propofol 1.5 mg.kg-1, followed, two minutes later, by alfentanil 7 micrograms.kg-1. Once the bronchial resistances had been assessed the patient was given a further 2 mg.kg-1 dose of propofol, and alfentanil 40 micrograms.kg-1. The patient was then intubated, and anaesthesia maintained with propofol 9 mg.kg-1.h-1, and alfentanil 15 micrograms.kg-1 every fifteen minutes. In all, bronchial resistances were measured on the day before surgery, after premedication but before the patient had been given any anaesthetic drug, two minutes after the first injection of propofol, two minutes after the first injection of alfentanil, and after extubation. There were no significant differences between the two groups. Despite the small number of patients included in this study, it would seem that hydroxyzine, propofol and alfentanil may be used safely in patients with hyperreactive bronchi.
Bilbault
P
P
Département d'Anesthésie-Réanimation, CHRU Hôpital Central, Nancy.
Boisson-Bertrand
D
D
Duvivier
C
C
Peslin
R
R
Laxenaire
M C
MC
D000328:Adult; D000403:Airway Resistance / Q000187:drug effects*; D015760:Alfentanil / Q000494:pharmacology*; D001249:Asthma / Q000503:physiopathology*; D001980:Bronchi / Q000187:drug effects*; D002985:Clinical Protocols; D004338:Drug Combinations; D005260:Female; D006801:Humans; D006919:Hydroxyzine; D008297:Male; D015742:Propofol / Q000494:pharmacology*
D004338:Drug Combinations; D015760:Alfentanil; D006919:Hydroxyzine; D015742:Propofol
Influence de l'association propofol-alfentanil sur les résistances bronchiques du sujet asthmatique.